HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): René Prêtre Ali Dodge-Khatami Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Tschuppert, S. Articles by Dodge-Khatami, A. Search for Related Content PubMed Articles by Tschuppert, S. Articles by Dodge-Khatami, A.

J Thorac Cardiovasc Surg 2008;135:78-82
© 2008 The American Association for Thoracic Surgery

Surgery for Congenital Heart Disease

The effect of ductal diameter on surgical and medical closure of patent ductus arteriosus in preterm neonates: Size matters

^a Division of Congenital Cardiovascular Surgery, University Children’s Hospital, University of Zurich, Zurich, Switzerland
^b Division of Pediatric Intensive Care, University Children’s Hospital, University of Zurich, Zurich, Switzerland
^e Division of Pediatric Cardiology, University Children’s Hospital, University of Zurich, Zurich, Switzerland
^c Clinic of Neonatology, University Hospital, University of Zurich, Zurich, Switzerland
^d Department of Biostatistics—University of Zurich, Zurich, Switzerland.

Received for publication May 24, 2007; revisions received June 14, 2007; accepted for publication July 9, 2007.

^_* Address for reprints: Ali Dodge-Khatami, MD, PhD, Division of Congenital Cardiovascular Surgery, University Children’s Hospital, University of Zurich, Steinwiesstrasse 75, 8032 Zurich, Switzerland. (Email: ali.dodge-khatami{at}kispi.uzh.ch).

Objective: We sought to analyze the effect of patent ductus arteriosus diameter on treatment success in premature neonates.

Methods: Among 537 consecutive neonates born between 1985 and 2005 with a diagnosed patent ductus arteriosus, 201 premature patients (<35 weeks’ gestation) treated for a hemodynamically significant patent ductus arteriosus were retrospectively reviewed. Two groups were compared: group MED (n = 154; successful treatment with indomethacin) and group FAIL (n = 47; failure of medication to reduce the patent ductus arteriosus diameter to hemodynamic insignificance).

Results: After unsuccessful medical treatment, 33 patients required surgical patent ductus arteriosus closure, 12 died before further possible treatment, and 2 were discharged home without clinical symptoms but with an open patent ductus arteriosus. Mean patent ductus arteriosus diameter in the FAIL group (2.8 ± 0.9 mm) was significantly larger than that in the MED group (2.4 ± 0.6 mm, P < .01). Assisted respiration time (ventilation plus continuous positive airway pressure) before patent ductus arteriosus closure was longer in the FAIL group (20 days) than in the MED group (9 days, P < .001) but was similar after patent ductus arteriosus closure. By using an index of patent ductus arteriosus diameter squared/birth weight (in square millimeters per kilogram), a cutoff value of less than 9 mm²/kg correctly predicts medical patent ductus arteriosus closure in 87.5% of patients. Values of greater than 9 mm²/kg correctly predict medication failure in 41.5% of patients.

Conclusions: In preterm babies requiring surgical patent ductus arteriosus closure, longer respiration times reflect a delay while attempting medical treatment, but respiration time is equally short between groups after shunt elimination. Medical treatment, although a valid first option, is likely to fail with larger patent ductus arteriosus diameters and lower birth weights. Unwarranted assisted respiration and corresponding hospital stay might be shortened by earlier surgical referral for patent ductus arteriosus closure in preterm babies with a patent ductus arteriosus index of greater than 9 mm²/kg.